Table 2.
Antimicrobial | Number of susceptible isolates/number of isolates tested | Susceptibility % |
---|---|---|
Ceftazidime | 33/38 | 87 |
Piperacillin-tazobactam | 33/37 | 89 |
Ciprofloxacin | 36/38 | 95 |
Levofloxacin | 35/37 | 95 |
Trimethoprim-sulfamethoxazole | 37/38 | 97 |
Gentamicin | 38/38 | 100 |
Cefepime | 37/37 | 100 |
Imipenem | 37/37 | 100 |
Meropenem | 37/37 | 100 |